Study of JK07 in Patients With Chronic Heart Failure

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.
Epistemonikos ID: 9bac2506a65247d150014214bd2d5cadf4bdd581
First added on: May 15, 2024